The First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary Endpoint
/PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing...
Source: prnewswire.com